Skip to content
lifestyle.smsolar.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nutshell Therapeutics (Shanghai) Co., Ltd.
Second NRF2 Degrader Enters Clinical Development: Nutshell Therapeutics’ NTS231 Received FDA IND Clearance
September 25, 2026